Wade M. Andrew 4
4 · AtriCure, Inc. · Filed Jan 17, 2020
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Wade M. Andrew
Vice President, Finance
Transactions
- Exercise/Conversion
Common Stock
2020-01-16$6.27/sh+10,000$62,700→ 155,120 total - Sale
Common Stock
2020-01-16$36.00/sh−10,000$360,000→ 145,120 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-01-16−10,000→ 15,000 totalExercise: $6.27From: 2013-10-25Exp: 2022-10-25→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]These shares were exercised pursuant to a 10b5-1 trading plan.
- [F2]These shares were sold pursuant to a 10b5-1 trading plan.
- [F3]These options were granted on October 25, 2012. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.